TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BLTE

Belite Bio Inc

Healthcare · Biotechnology

165.90$ -0.8% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BLTE
Line item 2020 2021 2022 2023 2024 2025
– -28.7% +141.3% +113.8% +60.7% +413.1%
– -32.1% +145.6% +110.1% +63.5% +236.1%
– -32.3% +142.7% +109.5% -64.1% +1,014.2%
– -32.3% +142.7% +109.5% +64.6% +239.3%
– -42.5% -17.4% +4,463.2% -31.5% +20.9%
– – – – – –
– +104.3% – – – –
– – – +10,535.5% +21.0% +23.2%
– +2.0% -91.7% +51.9% +49.9% +59.6%
– +68.2% +28.7% +72.7% +66.5% +63.3%
– – – +55.6% -10.4% -12.7%
– – – +117.9% +61.3% +428.4%
– – – – – –
– +161.7% -17.1% +33.1% +14.8% +9.8%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?